Philip J Barter1, Kerry-Anne Rye. Show Affiliations » 1. The Heart Research Institute and the Department of Medicine, University of Sydney, Australia. barterp@hri.org.au
Abstract
Mesh： See more » Anticholesteremic Agents/therapeutic useCardiovascular Diseases/drug therapyCardiovascular Diseases/etiologyCardiovascular Diseases/prevention & controlCholesterol, HDL/bloodCholesterol, LDL/bloodDose-Response Relationship, DrugDrug InteractionsHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effectsHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHypercholesterolemia/bloodHypercholesterolemia/complicationsHypercholesterolemia/drug therapyMuscular Diseases/chemically inducedNonprescription Drugs/adverse effectsNonprescription Drugs/therapeutic usePredictive Value of TestsRisk AssessmentSelf Medication
Substances： See more » Anticholesteremic AgentsCholesterol, HDLCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsNonprescription Drugs
Year: 2006 PMID： 16982953 DOI： 10.1161/CIRCULATIONAHA.105.604991
Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690